"Antibacterial effect and possible mechanism of action of 1,3,4-oxadiazole in Staphylococcus aureus"

Lett Appl Microbiol. 2024 Jan 2;77(1):ovad138. doi: 10.1093/lambio/ovad138.

Abstract

Staphylococcus aureus is one of the main etiological agents causing foodborne diseases, and the development of new antibacterial agents is urgent. This study evaluated the antibacterial activity and the possible mechanism of action of the 1,3,4-oxadiazole LMM6 against S. aureus. The minimum inhibitory concentration (MIC) of LMM6 ranged from 1.95 to 7.81 µg ml-1. The time-kill assay showed that 48-h treatment at 1× to 8× MIC reduced S. aureus by 4 log colony forming unit (CFU), indicating a bacteriostatic effect. Regarding the possible mechanism of action of LMM6, there was accumulation of reactive oxygen species (ROS) and an increase in the absorption of crystal violet (∼50%) by the cells treated with LMM6 at 1× and 2× MIC for 6-12 h. In addition, there was increased propidium iodide uptake (∼84%) after exposure to LMM6 for 12 h at 2× MIC. After 48 h of treatment, 100% of bacteria had been injured. Scanning electron microscopy observations demonstrated that LMM6-treated cells were smaller compared with the untreated group. LMM6 exhibited bacteriostatic activity and its mechanism of action involves increase of intracellular ROS and disturbance of the cell membrane, which can be considered a key target for controlling the growth of S. aureus.

Keywords: S. aureus; 1,3,4-oxadiazole; LMM6; antibacterial activity; mechanism of action.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Humans
  • Microbial Sensitivity Tests
  • Oxadiazoles / pharmacology
  • Reactive Oxygen Species
  • Staphylococcal Infections*
  • Staphylococcus aureus*

Substances

  • 1,3,4-oxadiazole
  • Reactive Oxygen Species
  • Anti-Bacterial Agents
  • Oxadiazoles